# Award #75N93026D00019

Definitive IDV Contract for Antimicrobial Testing with Element Materials Technology

**Buyer:** National Institutes of Health

**Award Amount:** $2,500.00
**Ceiling:** $2,500.00

**Awarded:** September 30, 2026
**Period of Performance:** Sep 30, 2026 - Sep 29, 2036

**Identifier:** 75N93026D00019
**NAICS:** 541714

This definitive indefinite-delivery vehicle (IDV) contract has been awarded to Element Materials Technology Iowa City Inc., a company that specializes in materials testing and analysis services. The contract centers on the in vitro assessment of antimicrobial activity, providing essential laboratory testing to measure the effectiveness of antimicrobial agents. This work plays a crucial role in advancing public health and safety by ensuring that antimicrobial products meet rigorous performance standards. The scope of work under this multi-year agreement includes detailed laboratory testing and evaluation services to support research initiatives and regulatory compliance in antimicrobial applications. The contract was competitively awarded, promoting transparency and fair opportunity in the procurement process. Spanning a decade from 2026 through 2036, this long-term agreement ensures continued support for the agency’s antimicrobial assessment needs. While specific contract vehicles or acquisition programs were not disclosed, this award represents a strategic partnership to deliver critical testing capabilities for the agency.

### Description

IN VITRO ASSESSMENT OF ANTIMICROBIAL ACTIVITY (IVAAA)

[View original record](https://www.usaspending.gov/award/CONT_IDV_75N93026D00019_7529)